articleTop 10% cited

High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

Journal of Hypertension · 2001 · Vol. 19(12) · pp. 2271–2277

Alexander G. Logan✉(University of Toronto)Sandra M. Perlikowski(Lunenfeld-Tanenbaum Research Institute)Andrew Mente(Lunenfeld-Tanenbaum Research Institute)András Tislér(Lunenfeld-Tanenbaum Research Institute)Ružena Tkáčová(Toronto Sleep Institute)Mitra Niroumand(Toronto Sleep Institute)Richard Leung(Toronto Sleep Institute)T. Douglas Bradley(Toronto Sleep Institute)

View via DOI Publisher page

Abstract

The extraordinarily high prevalence of OSA in these patients supports its potential role in the pathogenesis of drug-resistant hypertension, and justifies the undertaking of a randomized controlled trial to corroborate this hypothesis.

Obstructive Sleep Apnea Research Sleep and Wakefulness Research Sleep and related disordersMedicineBlood pressureBody mass indexAntihypertensive drugInternal medicineAmbulatory blood pressureDiastoleAmbulatoryCardiology

MeSH terms

AdultAgedAntihypertensive AgentsCross-Sectional StudiesDrug ResistanceDrug Therapy, CombinationFemaleHumansHypertensionMaleMiddle AgedObesitySleep Apnea SyndromesPrevalence

Citations

949

FWCI

5.68

field-weighted impact

References

Percentile

97%

vs. same field & year

Citations per year

Cited by

Obstructive Sleep Apnea